S-Biomedic NV is a Belgian skincare company developing microbiome-based products such as Sencyr for acne, eczema and rosacea.
Based in Belgium, S-Biomedic is a skincare company that targets the skin microbiome, with its main product Sencyr, which uses Living Skin Probiotics derived from the Cutibacterium microbe. The company was co-founded by Bernhard Paetzold and is led by CEO Veronika Oudova. In December 2022 Beiersdorf AG acquired a majority stake from investors including Investiere.ch and DSM Venturing, and Beiersdorf has worked with the company since 2018. Its Series A round raised EUR 2.00 mn, which is also its total funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in